Scope IP Bursary Scheme

Scope Independent Prescriber Bursary Scheme

What is the Scope Independent Prescriber Bursary Scheme?

2022 marks the first year of Scope Eyecare’s Independent Prescriber Bursary Scheme, which is designed to support Optometrists who wish to enhance their clinical skills and qualify as Independent Prescribers.


Through this new Bursary Scheme, Optometrists will be asked to submit an interesting patient case study where they believe having an IP qualification would have improved the patients experience and care. 

Award Details

8 participants will be shortlisted to present their cases, via Zoom to a judging panel early June. The three winners will receive a £1500 bursary to be used towards tuition fees to enhance their clinical skills and qualify as Independent Prescribers. The five runners up will each receive a £100 educational voucher.

How To Enter

Who Can Enter

See who can avail of the bursary and if your are eligible to apply

Pick & Prepare Your Case Entry

Identify your case and create your submission in line with the guidelines provided

Submit By 31st May 2022

Submit your case entry to the email address provided below


The Scope IP Bursary is designed to support Optometrists who wish to enhance their clinical skills and qualify as Independent Prescribers.

Scope is offering three bursaries of £1,500 each to be used towards tuition fees at a centre of their choice.


The bursary is open to all UK Optometrists planning to complete an IP qualification in order to improve their skills and patient care.


The application consists of two sections:


1. Submit an interesting patient case study where having an IP qualification would have improved the patients experience and care. Please use the template provided but feel free to add any additional details that you feel would enhance your application.


Points to include:

• Background
• Clinical History
• The patients presenting condition
• How you managed it
• Patient outcomes
• How would you manage it if you were IP qualified?
• How would this benefit the patient?


2. A paragraph on why you would like to study to become an Independent Prescriber. We are looking for candidates/recipients who see a real value in qualifying as an Independent Prescribing Optometrist. In a maximum of 1000 words we would like to hear what obtaining the qualification would mean


• to you personally
• to your clinical setting or practice
• to your patients


Applications for the 2022 bursary are invited until Tuesday 31st May 2022.


Selection of the winners will be completed by June 2022 and the winners will be notified by email and announced in the optometric press.


Click here to download the application form for your entry.

Once the application form is ready to be submitted please send to by Tuesday 31st May 2022.

Terms & Conditions

All applicants must agree to their case study submissions being used for further education or used on other materials that highlight how to manage patients in clinical practice. They may be also posted on the Scope Education Hub and SCOPE HCP website.


After completing the IP course winners will be expected to share their experiences using IP and provide 4 further interesting case discussions within the first 2 years of qualifying to help promote an IP qualification for Optometrists.


Submitted cases must be original (i.e. not previously published). The case must be submitted by the applicant who must be the author and should not be submitted by anyone else on their behalf.

The case study (including any images, figures, illustrations etc) shall:

• Not infringe upon the privacy or personal rights of others
• Not contain any sensitive information
• Not be the copyright of any other entity unless this is acknowledged

It is the authors responsibility to ensure that:

• They have obtained all necessary consent(s), approvals and authorisations in connection with the Case submitted.
• All the content of the Case, including the text, its title and media files have been stripped of all personal information that could be used to identify the patient.


Scope has the right to use, publish or reproduce any case studies submitted to them for promotional purposes or otherwise.


Winners of the bursary must complete the course to qualification, otherwise the bursary must be refunded to Scope.


Participants have the right to access, review, rectify, cancel or delete any personal data held by Scope Ophthalmics Ltd.

Registration is open!Reserve your spot for the next Dry Eye Well-being Seminar

The Benefits of Preservative Free Drops
  • Benzalkonium chloride (BAK) is the most frequently used preservative in preserved eye drops. BAK can induce corneal and conjunctival epithelial cell apoptosis, damage corneal nerves, delay wound healing, interfere with tear film stability and cause loss of goblet cells.3
  • The negative symptoms experienced through the use of BAK-preserved drops may impact adherence to the prescribed treatment or management regime.4
  • Preservative-free tear replacement is preferred in cases of frequent and chronic application.5
  • Patients with Dry Eye Disease (DED), especially those with severe DED who require dosing over 4 times daily with lubricants or who use ocular lubricants in conjunction with other chronic topical therapies such as glaucoma medications, should avoid the use of ocular lubricants containing preservative.3
HYLO-Tear and HYLO-Forte Price Comparison
ProductHYLO TearHYLO ForteEvolve HAHyabakThealoz Duo
Drug Tariff price1£8.50£9.50£5.99£8.99£7.99
Average duration of scripts (days)30.3130.6519.7827.0725.55
Annual cost to ICS per patient£102.36£111.85£110.53£128.43£107.73


*Analysed data for preservative free (PF) ocular lubricants from Cegedim’s THIN database, Jan 2020-Dec 2020 (Representative of 400+ GP practices & 3.2M patient population)